InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Explore the complete record of transactions filed by Bitterman Kevin, Director. Director active across 1 companies, notably Akero Therapeutics, Inc.. In total, 2 filings have been published. Total volume traded: €712k. The latest transaction was filed on 1 June 2021 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
€355,85616,544 shares@ €21.5097100.0% of flow
Common Stock
SEC:0001209191-21-037978·
€355,85616,544 shares@ €21.509750.0% of flow
Common Stock
SEC:0001209191-21-037978:0·
2 of 2 declarations
About Bitterman Kevin
Kevin Bitterman is a Board Member at Akero Therapeutics, Inc. He contributes to the strategic direction of the company, ensuring that decisions made by the board align with the company's growth objectives. His expertise in the biopharmaceutical field is an asset to the leadership team.
